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Introduction
The prevalence of obesity and obesity-related disease
has increased dramatically in recent years, which puts
a large population at risk of developing nonalcoholic
fatty liver disease (NAFLD).1 NAFLD is closely asso-
ciated with metabolic disorder, even in the non-
obese, non-diabetic population.2 NAFLD exists as a
spectrum of liver disease with characteristics of liver
fat accumulation.3 It may progress to nonalcoholic
steatohepatitis (NASH), liver cirrhosis and even liver
failure. In the United States and developed countries,
it is the most common liver disease, with the preva-
lence of NAFLD and NASH being around 20% and
2–3%, respectively. The incidence of NAFLD in-
creases to 57–74% in obese persons.1,4–6 In a study by
Adams et al, 37% of patients with NAFLD progressed
to fibrosis, 34% remained the same and 29% re-
gressed.7 NAFLD is now considered to be the most
common cause of abnormal liver function and pre-
sumed liver injury in Taiwan, exceeding even viral
hepatitis B.8
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Treatment of NAFLD includes weight reduction
and exercise, insulin-sensitizing drugs, antioxidants,
lipid-lowering drugs and other hepatoprotective
agents.9 Previous studies have shown body weight
loss by diet control and/or exercise-improved insulin
resistance, alanine aminotransferase (ALT)/aspartate
aminotransferase (AST) level, and hepatic steatosis in
NAFLD.10–16 Exercise intervention in those reports
included regular walking, jogging, stationary biking,
stepping, and aerobic exercise. Diet control was done
with a suggested daily calorie intake of 25 kcal/ideal
body weight (IBW), or by decreasing daily calorie
intake by 500 kcal or 20%. However, most previous
studies were conducted in Western countries, where
people consume more fat than people in Asia. To date,
no study has investigated the effects of varied thera-
peutic lifestyle modification programs on Taiwanese
with NAFLD. The purpose of the present study was to
compare the effects of varied therapeutic lifestyle mod-
ification programs on patients with NAFLD in Taiwan.
For our subjects, we chose stationary bicycling as an ap-
propriate intervention to achieve exercise effect while
having a low likelihood of causing sport-related injury.
Considering the differences in baseline, we selected
25 kcal/IBW daily calorie intake for diet control.
Methods
Subjects
Subjects were recruited from the Department of
Internal Medicine and the Women’s Weight Reduction
Clinic in the Department of Obstetrics and Gynecology,
Taiwan Adventist Hospital, between April 2006 and
December 2007. Subjects who had any 3 of the fol-
lowing features were included in the study: (1) central
obesity—an abdominal circumference (AC) ≥90cm for
men, ≥ 80 cm for women, or body mass index (BMI)
> 25 kg/m2; (2) total cholesterol level ≥ 200 mg/dL
or triglyceride level ≥150mg/dL; (3) high-density lipo-
protein cholesterol (HDL-C) level <40mg/dL for men,
< 50 mg/dL for women; (4) blood pressure ≥ 130/
≥ 85 mmHg (or under treatment for hypertension).
Patients were excluded if they had a history of alco-
hol abuse or chronic intake (> 1 drink/week confirmed
by self-reported questionnaire), diabetes, hepatitis B
or C, hypothyroidism, anemia or hyperlipidemia. Sub-
jects who could not participate in an aerobic exercise
program due to high risk of adverse events were also
excluded.
The study was approved by the Institutional Review
Board of Taiwan Adventist Hospital, and all subjects
provided written informed consent.
Subjects were divided into 3 groups: (1) diet-plus-
exercise group (DPE group, n = 16); (2) exercise group
(E group, n = 23); and (3) control group (C group,
n = 25). An ultrasound examination of the liver was
performed at baseline and at 10 weeks. At baseline
and at 5 weeks and 10 weeks, 3 further measurements
were taken: blood samples, anthropometric indices,
and a physical fitness test. Subjects in the DPE group
received guidance on a low-calorie balanced diet with
a suggested daily calorie intake of 25 kcal/IBW; the
range in daily calorie intake was 1,200–1,500 kcal.
DPE subjects also participated in a high-intensity sta-
tionary bicycle exercise program at a frequency of 1
hour twice a week for 10 weeks. In addition, they were
asked to record a diet diary and were monitored by a
dietician. Subjects in the E group received the same
10-week exercise program as the DPE group but
without any change in diet. All subjects performed
the exercise under a professional instructor.
Liver ultrasound
Liver ultrasound was performed by an expert gastroen-
terologist and graded on a scale of 0 to 3 (0 = none,
1 = mild, 2 = moderate, 3 = severe) at baseline and at
study end. Mild was recognized by slight increase in
liver echogenicity and relative preservation of echoes
from the walls of the portal vein.17 Moderate was rec-
ognized by moderate loss of echoes from the walls 
of the portal vein, particularly from the peripheral
branches, and moderate diffuse abnormally bright
echoes. Severe was recognized by a greater reduction
in beam penetration, loss of echoes from most of the
portal vein wall, and extensive abnormally bright
echoes.18,19
Blood samples
Blood samples were obtained after an overnight fasting
period of at least 8 hours. Levels of fasting glucose,
triglycerides, HDL-C, low-density lipoprotein choles-
terol, uric acid, AST, ALT and γ-glutamyltransferase
(γ-GT) were measured using commercial kits on an
automated analyzer (Synchron CX9; Beckman Coulter
Co., Fullerton, CA, USA). Fasting insulin levels were
also determined using commercial kits on an auto-
mated analyzer (Access Immunoassay System; Beckman
Coulter Co.). A homeostasis model assessment
(HOMA) was used to evaluate insulin resistance using
fasting insulin and fasting glucose levels as described
by Matthews et al.20 Insulin resistance was defined as
HOMA ≥3.0.21 Abnormal liver function was defined as
a serum level of AST ≥40IU/L (reference, 10–40IU/
L) and/or a serum level of ALT ≥ 45 IU/L (reference,
6–45 IU/L).
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Anthropometric indices
The anthropometric indices included BMI, AC, hip cir-
cumference (HC), and abdomen-to-hip ratio (AHR).
Physical fitness test
The physical fitness examination included cardiovas-
cular endurance, flexibility, muscular endurance and
resting heart rate performed in the exercise center of
Taiwan Adventist Hospital. Cardiovascular endurance
was measured using the 3-minute step-test. The sit-and-
reach test was used to measure flexibility, and the 1-
minute sit-up test was used to test measure muscular
endurance.
Statistical analysis
Results were expressed in terms of mean ± standard
deviation. The multi-measurement design of the study
allowed for analysis of adjusted comparisons of differ-
ences among the 3 groups using generalized estimating
equations (GEE).22 In addition, the ordinal scale of the
liver ultrasound results (0, 1, 2 and 3 implying none,
mild, moderate and severe, respectively) enabled com-
parisons to be performed by using ordinal regression,23
controlling for the same covariates as in the GEE mod-
els. All statistical analyses were performed using SPSS
version 15.0 (SPSS Inc., Chicago, IL, USA), and a 
p value < 0.05 was considered statistically significant.
Results
A total of 54 subjects with NAFLD were recruited,
including 15 in the C group, 23 in the E group, and
16 in the DPE group. There was no subject who
dropped out. Subjects in the DPE group cooperated
with the low-calorie balanced diet very well, and all
subjects adhered to the 10-week exercise program.
Table 1 lists the basic characteristics of the subjects at
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Table 1. Baseline characteristics of the study subjects*
Control group Exercise group Diet + exercise group 
p†
(n = 15) (n = 23) (n = 16)
Sex 0.60
Male 8 16 10
Female 7 7 6
Age (yr) 37.7 ± 6.6 36.0 ± 6.9 40.1 ± 6.2 0.16
Anthropometric indices
Body mass index (kg/m2) 29.3 ± 3.7 30.7 ± 4.3 30.2 ± 3.7 0.55
Body weight (kg) 84.2 ± 15.2 85.3 ± 12.1 83.3 ± 10.9 0.91
Abdominal circumference (cm) 98.4 ± 11.4 100.3 ± 10.9 97.4 ± 8.6 0.69
Hip circumference (cm) 107.7 ± 7.9 107.9 ± 6.7 108.1 ± 6.6 0.98
Abdomen-to-hip ratio 0.91 ± 0.06 0.93 ± 0.05 0.90 ± 0.05 0.35
Biochemical profile
Total cholesterol (mg/dL) 229.0 ± 23.7 224.1 ± 34.0 215.7 ± 23.9 0.42
Triglycerides (mg/dL) 162.6 ± 93.3 192.0 ± 100.4 165.9 ± 68.9 0.57
HDL-C (mg/dL) 42.7 ± 7.5 41.7 ± 9.4 41.8 ± 8.7 0.94
LDL-C (mg/dL) 154.0 ± 29.2 144.0 ± 32.8 140.7 ± 25.9 0.44
Fasting plasma glucose (mg/dL) 97.7 ± 8.3 93.9 ± 8.1 107.2 ± 18.7 0.01‡
Fasting plasma insulin (μU/mL) 12.8 ± 8.6 10.5 ± 5.0 9.0 ± 4.7 0.24
HOMA-IR index 3.1 ± 2.2 2.5 ± 1.2 2.4 ± 1.3 0.41
AST (IU/L) 30.7 ± 14.7 34.5 ± 13.0 36.6 ± 18.8 0.56
ALT (IU/L) 47.3 ± 30.1 54.0 ± 29.4 63.4 ± 49.2 0.47
γ-GT (IU/L) 34.0 ± 26.2 42.4 ± 32.7 40.1 ± 23.3 0.67
Severity of fatty liver on ultrasound 1.8 ± 0.7 1.8 ± 0.7 1.4 ± 0.5 0.16
Physical fitness
Cardiovascular endurance 50.5 ± 8.2 49.4 ± 6.1 48.4 ± 3.7 0.66
Flexibility (cm) 17.8 ± 11.5 16.5 ± 9.6 17.1 ± 12.3 0.94
Muscular endurance (number/min) 18.8 ± 7.5 23.1 ± 8.0 17.6 ± 9.6 0.12
Resting heart rate (per min) 78.1 ± 9.8 82.9 ± 12.5 75.3 ± 15.1 0.19
*Data presented as n (for categorical variables) or mean ± standard deviation (for continuous variables); †χ2 test for categorical data and F test for continuous
data; ‡p < 0.05.
the start of the study. No significant intergroup dif-
ferences were noted, with the exception of fasting
plasma glucose level. Table 2 shows the unadjusted
estimates of the effects. Compared with baseline,
mean body weight and AC were slightly, but not sig-
nificantly, decreased in the E and DPE groups. Reduc-
tions in the levels of total cholesterol, ALT and γ-GT
were significant only in the DPE group. Table 3 shows
the adjusted estimates using the GEE model. The
DPE group showed significant reductions in anthro-
pometric indices and demonstrated significant improve-
ments in the serum level of total cholesterol, insulin
sensitivity, liver biochemistry, severity of fatty liver,
physical fitness and diastolic blood pressure. Subjects
in the E group had significant improvements in some
anthropometric indices, insulin sensitivity, severity of
fatty liver, cardiovascular endurance and diastolic blood
pressure, whereas liver biochemistry was not signifi-
cantly changed. Compared with the E group, the
DPE group showed significantly greater reduction in
anthropometric indices (BMI, body weight, AC, HC),
total cholesterol, HDL-C, ALT, and γ-GT. The ultra-
sound score for the severity of fatty liver for the 3
groups at baseline and at study end are shown in
Table 4. There were no significant differences among
the 3 groups at the baseline ultrasound examination.
However, a statistically significant difference was seen
at study end (10 weeks).
Discussion
The present study demonstrated the effects of 10-
week therapeutic lifestyle programs—diet plus exer-
cise versus exercise only—on anthropometric indices,
serum cholesterol, liver biochemistry, insulin sensi-
tivity and severity of fatty liver on ultrasound in
patients with ultrasound-diagnosed NAFLD. With
regard to anthropometric indices, our study results are
in line with those of previous studies;12–16 we observed
that exercise alone and diet plus exercise significantly
decreased BMI and AC. We also found that DPE
group patients had significant reduction in body
weight. Ueno et al12 and Thomas et al15 reported sim-
ilar findings: after 3 and 6 months of diet and exercise
intervention, subjects with fatty liver had significant
weight loss.
This study showed that even short-term lifestyle
change with diet and exercise can markedly improve
liver biochemistry with the benefit of significant weight
loss. Our results are compatible with those of previous
studies.19,20,21 A recent study by Suzuki et al showed
that a reduction of 5% or more of original weight 
by diet control and regular exercise for 3 months was
associated with improvement in total cholesterol and
ALT levels.13 Sreenivasa Baba et al reported that calorie
restriction and regular aerobic exercise for 30 minutes
a day for 3 months resulted in normalization of liver
biochemistry (ALT, AST) in patients with nonalcoholic
steatohepatitis.24 Our data revealed that diet plus exer-
cise, but not exercise alone, decreased total cholesterol
by 11%, AST by 21%, ALT by 23%, and γ-GT by 37%.
According to previous reports, body weight loss is
correlated with reductions in AST and ALT levels.
Body weight loss > 5% is associated with significant
improvement in liver biochemistry,13 and Palmer and
Schaffner reported that even a 1% reduction in body
weight can improve ALT by 8.1%.16 Although the
exercise program in this study resulted in significant
reduction in BMI and AC, the change in liver bio-
chemistry was not statistically significant. A possible
explanation is that the exercise program was less stren-
uous or shorter in duration than those in previous
studies; body weight did not change significantly to
alter liver biochemistry.
Significant improvement in severity of intrahepatic
fat accumulation on ultrasound score was observed in
both the DPE and E groups. This finding is consistent
with those reported by others.25,26 Perseghin et al
showed that a higher level of habitual physical activity
is associated with lower intrahepatic fat content.25
Tamura et al demonstrated that calorie restriction for
2 weeks with or without exercise caused a 27% reduc-
tion in intrahepatic fat despite a minimal change in body
fat in type 2 diabetic patients.26
Significant improvement in fasting insulin levels as
well as HOMA-IR index were noted in both the DPE
and E groups in the present study. These findings are
compatible with those of previous reports.27–29
Exercise training had an independent effect on insulin
concentrations and resulted in lower insulin concen-
tration after a glucose challenge test.27,28 However,
exercise might not result in a significant change in
glucose concentrations.29 The role of exercise in
improving insulin sensitivity remains controversial. A
high-fat diet results in decreased muscle insulin sensi-
tivity. Exercise training may reverse the impairment,
resulting in improved insulin-stimulated glucose trans-
port and increasing the rates of fatty acid oxidation in
skeletal muscle.30 In the present study, we found that
when compared with the C group, although better
cardiovascular and muscular endurance were noted in
the DPE group, insulin resistance improvement was less
than that in the E group. The reason for this paradox-
ical finding is unknown. Possible explanations include
population bias due to a relatively small population
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and most subjects having a HOMA index < 3.0.
HOMA index is an indirect quantitative method and
more suitable for large sample size. Might it or other
reasons have caused the insoluble difference? Further
investigation is needed to answer the question. Addi-
tionally, when we compared the effects of exercise-only
and diet plus exercise, there was no significant dif-
ference in fasting insulin levels and HOMA-IR index
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Table 3. Adjusted estimates of the effects of exercise only and diet plus exercise compared with control
Effects*
Variables Exercise Diet + exercise Diet + exercise group
group group (compared with exercise only)
Anthropometric indices
Body mass index (kg/m2) −0.35‡ −1.62§ −1.31§
Body weight (kg) −0.76 −4.43§ −3.84§
Abdominal circumference (cm) −3.58§ −6.39§ −2.91§
Hip circumference (cm) −0.72 −2.45§ −1.77§
Abdomen-to-hip ratio −0.03§ −0.04§ −0.14
Biochemical profile
Total cholesterol (mg/dL) −5.15 −24.32§ −18.27§
Triglycerides (mg/dL) −7.06 −36.31 −24.52
HDL-C (mg/dL) −0.60 −2.61 −2.45‡
LDL-C (mg/dL) −2.31 −16.24 −13.13
Fasting plasma glucose (mg/dL) −1.02 −4.46 −0.17
Fasting plasma insulin (μU/mL) −5.11‡ −3.22‡ 1.29
HOMA-IR index −1.33‡ −0.97‡ 0.21
AST (IU/L) −4.15 −7.92‡ −3.25
ALT (IU/L) −3.27 −15.40‡ −10.39‡
γ-GT (IU/L) 0.08 −15.17§ −15.41§
Severity of fatty liver on ultrasound† −2.19‡ −2.85‡ −0.93
Physical fitness
Cardiovascular endurance 3.95‡ 4.55‡ 0.19
Flexibility (cm) 1.41 4.10‡ 2.42
Muscular endurance (number/min) −1.68 1.28 1.96
Systolic blood pressure (mmHg) −2.33 –2.19 1.05
Diastolic blood pressure (mmHg) −4.08‡ −6.13‡ −1.65
Resting heart rate (per min) 3.21 2.94 0.05
*Effect values were estimated using the generalized estimating equation method, and all effect values were adjusted for age, sex and the baseline measure-
ments of body mass index, fasting sugar and each variable; †data were ordinal, so the effect values were estimated using the ordinal regression method and
adjusted for age, sex and the baseline measurements of body mass index, fasting sugar and severity of fatty liver on ultrasound; ‡p < 0.05; §p < 0.01.
Table 4. Severity of fatty liver on ultrasound score in the 3 groups during the study period
χ2 test
Time
Liver ultrasound Control Exercise Diet + exercise
Total
Value
Exact significant score group group group
value (2-sided)
Initial 1 (mild) 5 8 9 22 4.101 0.402
2 (moderate) 8 11 7 26
3 (severe) 2 4 0 6
Total 15 23 16 54
10 wk 0 (none) 0 3 1 4 10.265* 0.050
1 (mild) 9 12 14 35
2 (moderate) 4 8 1 13
3 (severe) 2 0 0 2
Total 15 23 16 54
*p < 0.05.
between the 2 groups. This suggests that exercise
might play a key role in the improvement of insulin sen-
sitivity, and diet control might not provide significant
additional effects.
Limitations of the present study included the small
sample size and lack of histologic proof of NAFLD.
In spite of these limitations, this study confirms the
beneficial effect of therapeutic lifestyle programs for
Asian patients with NAFLD.
Our data suggest that 10-week diet-plus-exercise
and exercise-only therapeutic lifestyle programs are
both effective for improving anthropometric indices,
insulin sensitivity, ultrasound findings and physical
fitness in ultrasound-diagnosed NAFLD patients.
The improvement range from the diet-plus-exercise
program was more obvious than that of the exercise-
only program. Moreover, the diet-plus-exercise pro-
gram appeared to offer significant improvement 
in liver biochemistry, but the exercise-only program
did not.
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